Peri-domestic behaviour of African malaria vectors and the impact of insecticides

Lead Research Organisation: Liverpool School of Tropical Medicine
Department Name: Vector Biology

Abstract

The most effective and widely used malaria vector control measures use insecticides to target the vector in the home environment and account for 60% of global investment in malaria control today. With the arrival and rapid spread of insecticide resistance in African malaria vectors, the need to find new approaches to indoor vector control has become urgent. Existing tools and the majority of new approaches for vector control are designed to target Anopheles sp. peri-domestic behaviours to deliver impact. Yet despite its importance in malaria epidemiology and control, very little is known about mosquito behaviour within the human home. Knowledge is limited to simple basics such as where mosquitoes enter and exit the house and that they rest within the home after bloodfeeding. Key questions about how they approach the house, where they fly in three-dimensional space, which sensory cues are critical and how they influence flight or entry behaviour remain unanswered. This lack of knowledge becomes even more apparent when investigating how mosquitoes interact with insecticides in the domestic environment.
Small, fast-flying and nocturnally active, Anopheles mosquito behaviour is not easily studied. Progress in this field has been hampered by the technological challenge of tracking anophelines and insight into the behaviour of anophelines will ultimately be the key to more effective vector control. Moreover, such studies are best undertaken in the mosquito's natural environment, to ensure accuracy and reliability. Tackling this challenge, we have developed robust mosquito tracking technology that overcomes many of the obstacles that prevented studies previously. Our tracking system can provide detailed visual recordings of nocturnal mosquito activity indoors, at a rural setting in the field in Tanzania, allowing detailed observation and subsequent analysis of the behaviour of wild populations of the Anopheles malaria vectors.
The project will use the tracking equipment in an experimental hut system in the field in Tanzania to deliver an evidence-based characterisation of anopheline mosquito behaviour in the human home. We will also examine how insecticide treatments deployed in the home affect behaviour to determine more precisely how existing vector control tools function and how they might be improved.
This unique collaboration utilises state-of-the-art technology deployed in a resource-poor setting to search for solutions to a disease affecting millions worldwide. Its findings will be fundamental to increasing understanding of the mechanisms of existing vector control tools, whilst potentially identifying targets for new tools in the near future.

Technical Summary

Limited knowledge of malaria vector behaviour in the peri-domestic environment is a major obstacle to the development of better tools for vector control. We have developed robust mosquito tracking technology that overcomes many of those obstacles. The project will deploy the purpose-built and unique system in an experimental hut system at a rural setting in Tanzania, to record and analyse the behaviour of wild vector populations.
The first aim is to track and fully characterize endophilic and endophagic behaviour of Anopheles gambiae and other mosquitoes. In a specially constructed experimental hut, activity of mosquitoes responding to human volunteers will be recorded and analysed. Using human volunteers as 'bait', we will capture and describe the complete sequence of mosquito behaviour from arrival to exit, including the key events involved in orientation to, and bloodfeeding at humans. Data will be produced on entry and exit (location, timing), flight (flight type, 3D spatial location, velocity, tortuosity, saccades and other parameters) and resting (timing, location, duration) activities in periods of <3 days. We will use human volunteers of both sexes and a range of ethnicities and ages. We anticipate numerous valuable insights and the primary deliverable is detailed characterisation of Anopheles gambiae behaviour in the human home.
The second aim is to investigate behaviour in response to insecticide treatments. Here we will examine how insecticide-based interventions (long-lasting insecticide-treated bednets and durable wall linings) affect behaviour, to explore modes of action of existing tools. Fundamental to our study is the eventual translation of basic behaviour findings to design new tools; hence we will test mosquito response to a new, patent pending, LLIN design.
The findings will deliver important evidence for understanding mechanisms of existing vector control tools, whilst potentially identifying targets for new tools.

Planned Impact

The project's primary goal is the enhancement of basic knowledge of the biology of mosquitoes, an essential step towards the rational design of effective control tools and strategies for reducing human malaria. Economic and societal impacts would impact primarily in sub-Saharan Africa, but be relevant to any malaria-endemic country. In the longer term, the same vector control tools could also be very effective against other diseases transmitted by other mosquitoes and arthropods.

Reducing the burden of malaria via improved vector control
The burden of malaria is one of mankind's greatest challenges. Globally, an estimated 3.4 billion people are at risk of malaria. In 2012, over 200 million cases and 627,000 deaths occurred, mostly in Africa where 77% were in children under 5 years of age. Global investment in malaria prevention and elimination is at an all-time high, and improved vector control tools remain a top priority if recent impacts on malaria are to be sustained. Rapidly emerging insecticide resistance represents an imminent threat. Application and usage of many insecticides and other chemical treatments, both existing and in-development, are limited for safety reasons, compromising the arsenal of tools available for improving vector control and for the management of insecticide resistance. Delivery of such new tools is a priority for WHO and the Global Malaria Action Plan.
Our proposal tackles these challenges head-on and our findings will be of immediate value and direct interest to WHO, Ministries of Health, NGOs, donor communities and the private sector, ultimately benefitting malaria-affected communities in endemic countries.

Ensuring sustainable cost-effective malaria control tools
Not all vector control tools that effectively target mosquitoes will also be suitable for deployment in disease-endemic communities, as numerous issues surrounding user perception of efficacy and benefit, as well as potential for routine, correct usage and frequency and cost of replenishment over time must all be considered. The applicants' experience in this respect will ensure that projects aims are developed, and outputs delivered, with a clear understanding of the realities and challenges of implementing effective sustainable vector control in sub-Saharan Africa.

Reducing insecticide quantities and risks
The global community is aware and highly sensitive to the risks of side-effects occurring during insecticide use. Our goal is to design tools that deliver insecticides in ways that reach the target pest species efficiently, whilst minimizing quantities of insecticide used and risks to users within and beyond the home.

Improved capacity for malaria research in Tanzania
Capacity strengthening is a cornerstone of LSTM's mission and this collaboration continues a long and productive association with many institutions in Tanzania by LSTM staff, including the PI. By undertaking virtually all of the experimental work in Tanzania, we are mutually dependent. UK partners will further ensure our commitment to colleagues in Tanzania by seeking additional training support for the PGRA, Jackline Martine, and also for other NIMR staff when future recruiting opportunities arise.
 
Description Consultant advisor to the WHO Pre-Qualification Team (PQT) Vector Control
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guideline committee
URL https://www.who.int/pq-vector-control/about/en/
 
Description Invited member of the Expert Scientific Advisory Committee (ESAC) for the "USAID Grand Challenge for prevention of Zika and Future Threats"
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guideline committee
URL https://www.usaid.gov/grandchallenges/zika
 
Description Developing entomological indicators to assess the public health value of next generation LLINs
Amount $3,884,815 (USD)
Funding ID OPP120015 
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 02/2019 
End 07/2022
 
Description GCRF Growing Research Capability
Amount £6,467,378 (GBP)
Organisation Research Councils UK (RCUK) 
Sector Public
Country United Kingdom
Start 04/2017 
End 04/2021
 
Description Invited grant proposal
Amount $2,000,045 (USD)
Funding ID OPP1159078 
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 01/2017 
End 12/2019
 
Description Wellcome Trust Collaborative Award
Amount £2,474,741 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 05/2016 
End 06/2019
 
Title Behavioural bioassays for evaluating insecticide treated bednet efficacy against mosquito populations. 
Description "Video Cone" "VICTA" and "Baited box" tests A set of bench top mosquito behavioural assays to measure efficacy of insecticide-treated bednets or (potentially) to measure resistance in wild populations of vectors. The rationale and protocols for the tests arise directly from knowledge obtained in this research. 
Type Of Material Technology assay or reagent 
Year Produced 2022 
Provided To Others? Yes  
Impact Not yet. The first test, Video Cone test, has been submitted and the next two are in preparation for publication in the coming year. In due course, we hope the tests will be adopted by WHO Pre qualification as an appropriate method of evaluation for inclusion in a portfolio of evidence attesting to a product's suitability. 
 
Title Data from: Barrier bednets target malaria vectors and expand the range of usable insecticides 
Description Transmission of Plasmodium falciparum malaria parasites occurs when nocturnal Anopheles mosquito vectors feed on human blood. In Africa, where malaria burden is greatest, bednets treated with pyrethroid insecticide were highly effective in preventing mosquito bites and reducing transmission, and essential to achieving unprecedented reductions in malaria until 2015. Since then, progress has stalled and with insecticidal bednets losing efficacy against pyrethroid-resistant Anopheles vectors, methods that restore performance are urgently needed to eliminate any risk of malaria returning to the levels seen prior to their widespread use throughout sub-Saharan Africa. Here we show that the primary malaria vector Anopheles gambiae is targeted and killed by small insecticidal net barriers positioned above a standard bednet, in a spatial region of high mosquito activity but zero contact with sleepers, opening the way for deploying many more insecticides on bednets than currently possible. Tested against wild pyrethroid-resistant Anopheles gambiae in Burkina Faso, pyrethroid bednets with organophosphate barriers achieved significantly higher killing rates than bednets alone. Treated barriers on untreated bednets were equally effective, without significant loss of personal protection. Mathematical modelling of transmission dynamics predicted reductions in clinical malaria incidence with barrier bednets that exceeded those of 'next-generation' nets recommended by WHO against resistant vectors. Mathematical models of mosquito-barrier interactions identified alternative barrier designs to increase performance. Barrier bednets that overcome insecticide resistance are feasible using existing insecticides and production technology, and early implementation of affordable vector control tools is a realistic prospect. 
Type Of Material Database/Collection of data 
Year Produced 2019 
Provided To Others? Yes  
 
Title MOSQUITO BED NET ASSEMBLY 
Description Mosquito bed net assembly 10a-h includes a mosquito bed net (12) impregnated with a first insecticide and a barrier member 16a-h located above an upper surface (14) of the bed net (12) and being impregnated with a second insecticide. In use, bed net assembly 16a-h increases the likelihood of delivering a lethal dosage of insecticide to mosquitoes flying in frequently-visited areas of a bed net, without increased attendant health risk to a user. 
IP Reference WO2015063455 
Protection Patent granted
Year Protection Granted 2015
Licensed No
Impact None yet. Undergoing the first large scale trial in DRC later this year.
 
Title Barrier bednets 
Description We demonstrated how 'panels' or barriers of insecticide-treated netting positioned on the roof of a standard rectangular ITN increased the lethality of a deltamethrin-treated bednet against pyrethroid-resistant mosquitoes. Such upright roof barriers intercept mosquitoes where we 'd shown previously, the highest levels of malaria vector activity are known to occur and where the insecticide-treated material cannot contact the sleeper. Such a BBNet could potentially increase the range of candidate insecticides, by making newer expensive insecticides affordable, allowing higher concentrations of the a.i. or permitting the use of some insecticides currently 'unsafe for skin contact'. In addition to increasing treatment choice, BBnets would require less insecticide per net, which ultimately translates as safer cheaper nets, less toxic waste and reduced impacts on non-target fauna. We are now awaiting the start of a trial in DRC, where a PBO-treated BBNet will be evaluated in comparison with a standard PBO net. we are actively seeking support for further trials and for additional refinement of the concept to ensure the likelihood it will be adopted and used by communities in Africa. 
Type Products with applications outside of medicine
Current Stage Of Development Refinement. Non-clinical
Year Development Stage Completed 2019
Development Status Actively seeking support
Impact The device has been shown to be highly effective experimentally (and continues to do so) but until it has demonstrated its ability to do so at the community level in a clinical trial, its full potential remains unproven. However, an opportunity to incorporate this as an additional arm within a planned trial of ITNs in the Democratic Republic of Congo has arisen. The trial will begin in 2023, and is scheduled to run for 24 months. iIt has not yet been registered and has no unique identifier. 
 
Description Conference "Mosquito-borne viruses: can we build on commonalities to pre-empt the future?" the Wellcome Trust, London 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Conference titled "Mosquito-borne viruses: can we build on commonalities to pre-empt the future?" on 5-7 October 2016, London. A joint WHO-Wellcome Trust three-day meeting on mosquito-borne viral diseases; I was a session chair and presenter.

The Wellcome Trust hosted this WHO conference in London, UK on October 5th to 7th 2016. The meeting covered a variety of topics concerning mosquito born viruses, including vaccines, vector control, medicines and blood products, diagnostics, regulatory issues, and yellow fever. An executive summary is now available on request and an official synopsis of this meeting will be published in early 2017.

Attendance by and conversations with DfID staff, are believed to have influenced the prioritising of Aedes-borne arboviral diseases in the 2017 subsequent funding call.
Year(s) Of Engagement Activity 2016
 
Description Presentation 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact Presentation to Bill Gates (BMGF), George Osborne (Chancellor for the Exchequer, UK Gov), Justine Greening (DfID, UK), Industry heads and media reps, during institution visit to announce the £3billion Ross Fund.
Year(s) Of Engagement Activity 2016